Kolkata: Private hospitals in Kolkata welcome people who nod to Covaxin and hope they will now be able to use at least some of the shares they have held for months and who will expire in three weeks.
Some said they looked at big losses and made that vaccines would be wasted unless there was an immediate surge in the number of recipients.
At least two hospitals plan to continue their shares to a government-free government hospital.
AMRI Hospital was abandoned with 4,800 covaxin doses worth Rs 50 Lakh.
NOD has come a little late for the existing shares to use, feel the CEO of Rupak Barua.
“We don’t expect to hurry to Covaxin now because most have got the first dose.
The impact of this late Aniat will be slow and will not really help dispose of the stock we hold.
If the government gave permission for emergency administration to the lower age group 18 Year, it will make a difference, “Barua said.
Amri has provided 10-15 doses of covaxin a day.
“At best, it can go up to 40-50 which will not be enough.
So, we have written to various clubs and associations to help us hold offshore camps where this can be used,” Barua added.
He said the hospital could contribute residual shares to a government hospital soon.
Leerful hospital is burdened with 500 covaxin doses.
Daily consumption has been less than 10 for several months.
Often, it’s zero.
“We did not have a Covaxin recipient on Thursday even though we nodded.
We tried to contact the recipient and told them that it was now recognized throughout the world.
Query has come but people are not sure.
So, we are headed for the kefanite,” said CEO of Peerless Hospital Sudipta Mitra .
The current country has a stock of 15 doses of lakh covaxin which is used mostly on the second dose recipient.
“We will start giving the first dose after we get the next stage of the 11 doses of Lakh Covaxin which might reach in the next two days,” said Ashim Das Malang, a family-family welfare official.
Covaxin supplies are erratic and shorter windows for the second dose, regardless of who does not recognize that prevents foreign journey, is the reason why it was rejected by the recipient, said the Education & Research Institute of Postgraduate Medical (IPGMER) Diplification Sarkar.
Belle Vue Clinic Internal Medical Consultant Rahul Jain felt that the covishield enjoyed the ‘first drive’ of the advantage